Title

Presenter(s)

Details

Exploring Novel Cancer Therapeutics with Generative Design and AI

Laurent Hoffer, OICR

Learn how OICR accelerates the discovery of higher quality lead compounds using BIOVIA’s  AI and Generative Design solution

Collaborative Virtual Plus Real Small Molecule Therapeutics Design

Kevin Cassidy, BIOVIA

 Learn about BIOVIA’s end-to-end solution for Small Molecule Drug Discovery on the 3DEXPERIENCE Cloud platform

Humanization and Developability Assessments in Engineering Multi-Specific Protein Therapeutics

Mahiuddin Ahmed, VITRUVIAE

Learn how VITRUVIAE uses BIOVIA Discovery Studio to accelerate the design of multi-specific biologics

Drug Discovery with Physics Based Modeling Enhanced by OpenFold/AlphaFold2 

Tien Luu, BIOVIA

Learn about the most recent developments in BIOVIA Discovery Studio Simulation on the 3DEXPERIENCE Cloud platform

Application of AI and Machine Learning Techniques to the Analysis of Dynamic Protein Sequences

David Kombo, Sanofi

Learn how Sanofi uses BIOVIA Pipeline Pilot to study dynamic protein sequences

Accelerating Trustworthy Scientific Discovery with Next Generation Compute-in-Memory Hardware

George Williams, GSI Technology

Learn how GSI Technology collaborated with Weizmann Institute to accelerate large-scale circular fingerprint searches on BIOVIA Pipeline Pilot at low threshold for drug discovery

Strategic Partnerships for Drug Discovery Across Different Modalities

Deepa Pandit, BIOVIA

Learn how you can partner with BIOVIA Contract Research to leverage proprietary Artificial Intelligence/Machine Learning (AI/ML) and multiscale modeling & simulation methods to accelerate the discovery and development of both, small molecule therapeutics and biotherapeutics.